Marijuana Use Not Linked to Risk of Arrhythmias After Acute MI

Share this content:
Marijuana Use Not Linked to Risk of Arrhythmias After Acute MI
Marijuana Use Not Linked to Risk of Arrhythmias After Acute MI

WEDNESDAY, May 9, 2018 (HealthDay News) -- For patients with acute myocardial infarction (AMI), marijuana use is not associated with increased risk of ventricular tachycardia/ventricular fibrillation (VT/VF) or cardiac arrest, according to a study presented at the annual meeting of the Heart Rhythm Society, held from May 9 to 12 in Boston.

Cecelia Johnson-Sasso, from the University of Colorado School of Medicine in Aurora, and colleagues compared clinical profiles and in-hospital outcomes for reported marijuana users and non-users admitted with a primary diagnosis of AMI.

The researchers found that marijuana use was reported by 3,854 of the 1,273,897 patients admitted with AMI. Compared with non-users, marijuana users tended to be younger, male, and were less likely to have coronary artery disease or coronary risk factors. Overall, 9.7 percent of both marijuana users and non-users experienced VT/VF or cardiac arrest (P = 0.94); 4.5 and 8.7 percent, respectively, experienced atrial fibrillation; and 4 and 6 percent, respectively, died. In multivariate analysis, the risk for VT/VF or cardiac arrest did not differ for users versus non-users (odds ratio, 1.01; P = 0.81). Marijuana users had lower in-hospital mortality (odds ratio, 0.79; P = 0.016) and a trend toward reduced risk of atrial fibrillation (odds ratio, 0.85; P = 0.054).

"Our study is the first to examine the relationship between marijuana use after a heart attack and various arrhythmias and we did not see a negative connection," a coauthor said in a statement.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »